Healthcare provider profile · identity verified

Thomas Petryk, MD

Allopathic & Osteopathic Physicians|Family Medicine · NEWARK, OH · NPI 1245210244

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Thomas Petryk, MD received $49.67 in general payments during 2025 across 3 reported records.

E.R. Squibb & Sons, L.L.C. accounted for 66.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.

E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 533 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$49.67

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$33.25	66.9%	2	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$16.42	33.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$49.67	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ELIQUIS Normalized: eliquis	Drug	E.R. Squibb & Sons, L.L.C.	$18.15	1	2025
Source payment records 2025-04-17 · E.R. Squibb & Sons, L.L.C. · $18.15 · Open Payments source
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$16.42	1	2025
Source payment records 2025-07-17 · Axsome Therapeutics, Inc. · $16.42 · Open Payments source
CAMZYOS Normalized: camzyos	Drug	E.R. Squibb & Sons, L.L.C.	$15.10	1	2025
Source payment records 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $15.10 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	533	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713	Eliquis · 2024 Exact normalized brand match · 1 Part D row	533	96

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1374	276
Atorvastatin Calcium	Atorvastatin Calcium	1353	314
Rosuvastatin Calcium	Rosuvastatin Calcium	1005	265
Amlodipine Besylate	Amlodipine Besylate	852	217
Losartan Potassium	Losartan Potassium	654	164
Furosemide	Furosemide	649	144
Lisinopril	Lisinopril	636	172
Omeprazole	Omeprazole	577	142
Metoprolol Succinate	Metoprolol Succinate	562	155
Eliquis	Apixaban	533	96
Potassium Chloride	Potassium Chloride	507	109
Metformin Hcl	Metformin Hcl	499	122
Sertraline Hcl	Sertraline Hcl	499	106
Gabapentin	Gabapentin	479	114
Valsartan	Valsartan	472	111
Pantoprazole Sodium	Pantoprazole Sodium	448	109
Metoprolol Tartrate	Metoprolol Tartrate	440	98
Simvastatin	Simvastatin	385	87
Trazodone Hcl	Trazodone Hcl	383	87
Tamsulosin Hcl	Tamsulosin Hcl	381	89
Tramadol Hcl	Tramadol Hcl	369	79
Hydrochlorothiazide	Hydrochlorothiazide	362	98
Buspirone Hcl	Buspirone Hcl	357	67
Pioglitazone Hcl	Pioglitazone Hcl	332	80
Clopidogrel	Clopidogrel Bisulfate	327	82
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	288	66
Carvedilol	Carvedilol	281	69
Famotidine	Famotidine	278	68
Glimepiride	Glimepiride	273	73
Duloxetine Hcl	Duloxetine Hcl	270	50
Alendronate Sodium	Alendronate Sodium	259	79
Donepezil Hcl	Donepezil Hcl	251	45
Alprazolam	Alprazolam	245	56
Lorazepam	Lorazepam	229	57
Allopurinol	Allopurinol	202	47
Albuterol Sulfate Hfa	Albuterol Sulfate	197	75
Mirtazapine	Mirtazapine	194	42
Farxiga	Dapagliflozin Propanediol	177	45
Oxycodone Hcl	Oxycodone Hcl	177	38
Ezetimibe	Ezetimibe	172	47
Quetiapine Fumarate	Quetiapine Fumarate	171	26
Prednisone	Prednisone	159	89
Levetiracetam	Levetiracetam	147	24
Baclofen	Baclofen	142	30
Finasteride	Finasteride	141	32
Jardiance	Empagliflozin	140	23
Pregabalin	Pregabalin	134	18
Calcitriol	Calcitriol	133	28
Chlorthalidone	Chlorthalidone	131	43
Citalopram Hbr	Citalopram Hydrobromide	128	29
Bisoprolol Fumarate	Bisoprolol Fumarate	126	28
Memantine Hcl	Memantine Hcl	125	29
Zolpidem Tartrate	Zolpidem Tartrate	124	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	122	25
Divalproex Sodium	Divalproex Sodium	121	19
Glipizide	Glipizide	121	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	121	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	120	29
Spironolactone	Spironolactone	120	30
Warfarin Sodium	Warfarin Sodium	120	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	109	32
Escitalopram Oxalate	Escitalopram Oxalate	108	23
Fluoxetine Hcl	Fluoxetine Hcl	104	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	104	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	103	73
Montelukast Sodium	Montelukast Sodium	100	27
Pravastatin Sodium	Pravastatin Sodium	99	28
Olanzapine	Olanzapine	98	suppressed
Aripiprazole	Aripiprazole	97	12
Meloxicam	Meloxicam	97	22
Methadone Hcl	Methadone Hcl	95	11
Hydralazine Hcl	Hydralazine Hcl	91	29
Methenamine Hippurate	Methenamine Hippurate	91	12
Nystatin	Nystatin	90	29
Venlafaxine Hcl	Venlafaxine Hcl	90	15
Klor-Con M20	Potassium Chloride	89	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	88	60
Tizanidine Hcl	Tizanidine Hcl	88	21
Venlafaxine Hcl Er	Venlafaxine Hcl	88	16
Oxybutynin Chloride	Oxybutynin Chloride	86	30
Fenofibrate	Fenofibrate	83	23
Clonazepam	Clonazepam	82	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	22
Fenofibrate	Fenofibrate,micronized	81	17
Esomeprazole Magnesium	Esomeprazole Magnesium	79	21
Bupropion Hcl Sr	Bupropion Hcl	78	14
Digoxin	Digoxin	78	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	76	16
Doxycycline Hyclate	Doxycycline Hyclate	76	48
Latanoprost	Latanoprost	76	13
Ropinirole Hcl	Ropinirole Hcl	75	17
Synthroid	Levothyroxine Sodium	75	23
Ozempic	Semaglutide	74	21
Propranolol Hcl	Propranolol Hcl	72	suppressed
Cefdinir	Cefdinir	71	52
Meclizine Hcl	Meclizine Hcl	71	26
Cephalexin	Cephalexin	68	32
Atenolol	Atenolol	67	17
Clonidine Hcl	Clonidine Hcl	67	18
Amitriptyline Hcl	Amitriptyline Hcl	65	21
Temazepam	Temazepam	65	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	64	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	63	36
Xarelto	Rivaroxaban	63	18
Bupropion Xl	Bupropion Hcl	62	16
Trulicity	Dulaglutide	62	17
Azithromycin	Azithromycin	59	40
Paroxetine Hcl	Paroxetine Hcl	59	16
Fluticasone Propionate	Fluticasone Propionate	58	21
Topiramate	Topiramate	57	11
Primidone	Primidone	56	14
Fentanyl	Fentanyl	55	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	55	32
Oxybutynin Chloride Er	Oxybutynin Chloride	55	15
Ondansetron Hcl	Ondansetron Hcl	53	27
Sumatriptan Succinate	Sumatriptan Succinate	53	15
Fiasp Flextouch	Insulin Aspart (Niacinamide)	50	suppressed
Verapamil Er	Verapamil Hcl	50	11
Triamcinolone Acetonide	Triamcinolone Acetonide	49	27
Labetalol Hcl	Labetalol Hcl	48	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	46	11
Celecoxib	Celecoxib	46	12
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	16
Tresiba Flextouch U-100	Insulin Degludec	46	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	11
Januvia	Sitagliptin Phosphate	44	suppressed
Testosterone Cypionate	Testosterone Cypionate	44	16
Enalapril Maleate	Enalapril Maleate	43	13
Nifedipine Er	Nifedipine	43	suppressed
Doxepin Hcl	Doxepin Hcl	42	suppressed
Lamotrigine	Lamotrigine	42	suppressed
Lithium Carbonate	Lithium Carbonate	42	suppressed
Carbamazepine	Carbamazepine	41	suppressed
Ondansetron Odt	Ondansetron	40	18
Novolog Flexpen	Insulin Aspart	39	14
Divalproex Sodium Er	Divalproex Sodium	38	suppressed
Risperidone	Risperidone	37	suppressed
Cilostazol	Cilostazol	36	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	12
Acetic Acid	Acetic Acid	35	suppressed
Amantadine	Amantadine Hcl	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Midodrine Hcl	Midodrine Hcl	35	suppressed
Torsemide	Torsemide	35	suppressed
Lovastatin	Lovastatin	34	suppressed
Morphine Sulfate	Morphine Sulfate	34	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	33	suppressed
Benztropine Mesylate	Benztropine Mesylate	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Diazepam	Diazepam	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	18
Methotrexate	Methotrexate Sodium	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Ketoconazole	Ketoconazole	28	18
Nitroglycerin	Nitroglycerin	28	23
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	28	suppressed
Oxcarbazepine	Oxcarbazepine	28	suppressed
Sildenafil Citrate	Sildenafil Citrate	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Droplet Pen Needle	Pen Needle, Diabetic	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Fluconazole	Fluconazole	27	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	26	suppressed
Colchicine	Colchicine	26	suppressed
Entacapone	Entacapone	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Levofloxacin	Levofloxacin	26	16
Risperdal Consta	Risperidone Microspheres	26	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	25	25
Calcium Acetate	Calcium Acetate	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Levemir Flexpen	Insulin Detemir	25	12
Ramipril	Ramipril	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	11
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Methimazole	Methimazole	22	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Trintellix	Vortioxetine Hydrobromide	20	suppressed
Armour Thyroid	Thyroid,pork	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Rexulti	Brexpiprazole	18	suppressed
Rivastigmine	Rivastigmine	18	suppressed
Silodosin	Silodosin	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Byetta	Exenatide	17	suppressed
Cimetidine	Cimetidine	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nyamyc	Nystatin	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Xifaxan	Rifaximin	17	suppressed
Acarbose	Acarbose	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Estradiol	Estradiol	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Metolazone	Metolazone	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Prolia	Denosumab	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Enulose	Lactulose	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Haloperidol	Haloperidol	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Novolin R Flexpen	Insulin Regular, Human	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Aristada	Aripiprazole Lauroxil	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	13	suppressed
Rufinamide	Rufinamide	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Indapamide	Indapamide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Modafinil	Modafinil	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$49.67 · 3 records	E.R. Squibb & Sons, L.L.C.	Auvelity, CAMZYOS, ELIQUIS	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error